PATENT CLAIM ANALYSIS

Application Number: 16352499
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-09
Patent Classification: ["514", "367000"]

Abstract:
The present invention provides methods for parenterally administering riluzole to subjects in need of treatment.

Claim (Index 13):
The method of  claim 11 , wherein the parenterally administered parenterally administered riluzole composition comprises about 0.4 mg to about 10 mg per ml of riluzole dissolved in about 1% (w/v) to about 10% (w/v) \u00df-cyclodextrin and an aqueous solvent.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 99.0
- Lexical Diversity: 1.0
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15664937', '14955674', '16157343', '12779850', '15872505']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7215117624773972
- 35 USC 102 Novelty (BERT): 0.651601690042557
- Combined Prediction Score: 0.7145207552339132
- Mean Citation Score: 294.37560599999995
- Max Citation Score: 608.2062400000002
- Similarity Product: 583.7979693687441

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test